- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation
- Locations
-
- Banner MD Anderson Cancer Center at Banner Gateway Medical Center Gilbert, Arizona, United States
- City of Hope - Duarte Cancer Center Duarte, California, United States
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
Clinical trial condition
EGFR Mutation
Explore clinical trials studying EGFR Mutation. Study availability and eligibility vary by location and protocol.
10 public trials
1 recruiting study
EGFR Mutation trial results
Enrolling by Invitation
Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance
NCT07122882
- Conditions
- ALK Fusion-positive Solid or CNS Tumors, BRAF V600 Mutation, Central Nervous System Neoplasms, +15 more
- Locations
-
- Chang Gung Memorial Hospital Linkou Branch Taoyuan, Taiwan
Not Yet Recruiting
Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study
NCT07365410
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
Not Yet Recruiting
A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer
NCT07285148
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Memorial Sloan Kettering Cancer Center David H, Koch Center lor Cancer Care New York, United States
Not Yet Recruiting
High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
NCT06971406
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
- Locations
-
Not specified
NCT06378658
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States
NCT06329895
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- PAREXEL International Early Phase Clinical Unit (London) Harrow, United Kingdom
NCT06360211
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States
Completed
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants
NCT06221475
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- ICON plc Groningen, Netherlands
NCT06348888
- Conditions
- Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States